 Aditxt Inc NASDAQ: ADTX has agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral therapies. AiPharma Global holds exclusive rights to AviganReeqonusQifenda and all formulations of favipiravir, a broad spectrum oral antiviral drug that targets COVID-19 and other infectious diseases. 